Protalix BioTherapeutics, Inc. Contract with Customer, Liability, Noncurrent
Protalix BioTherapeutics, Inc. (PLX) had Contract with Customer, Liability, Noncurrent of $0 as of 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2023-02-27
- 2022-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2022-06-30: Contract with Customer, Liability, Noncurrent $5.89M.
- 2022-03-31: Contract with Customer, Liability, Noncurrent $5.89M.
- 2021-12-31: Contract with Customer, Liability, Noncurrent $11.79M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2022-06-30 | $5.89M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $5.89M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $11.79M 10-K · filed 2023-02-27 |
| 2021-09-30 | $5.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.27M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $858.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.72M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.53M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.12M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $7.13M 10-Q · filed 2020-06-01 |
| 2019-12-31 | $16.98M 10-K · filed 2021-03-30 |
| 2019-09-30 | $28.59M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $34.91M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $32.98M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $33.03M 10-K · filed 2020-03-12 |
| 2018-09-30 | $33.49M 10-Q · filed 2019-03-18 |
| 2018-06-30 | $21.64M 10-Q · filed 2019-03-18 |
| 2018-03-31 | $22.38M 10-Q · filed 2019-03-18 |
| 2017-12-31 | $25.02M 10-Q · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |